Navigation Links
UK Based Machinery Manufacturer, SEPHA, Thrives Despite Downturn
Date:1/23/2010

The private equity backed manufacturing firm, Sepha, has bucked the economic downturn with a 33% increase in sales for 2009. Sepha Ltd which is based in Northern Ireland, manufactures innovative non-destructive leak testing, deblistering and lab-scale blister packing machines for the pharmaceutical industry. Much of its growth has come from export markets, particularly the low labour cost economies of India, Asia and South America.

(Vocus) January 21, 2010 -- A UK manufacturing company has bucked the economic downturn with an increase in sales of 33% in 2009*. Sepha Ltd which is based in Northern Ireland, manufactures innovative non-destructive leak testing, deblistering and lab-scale blister packing machines for the pharmaceutical industry. Much of its growth has come from export markets, particularly the low labour cost economies of India, Asia and South America. Sepha’s Chief Executive, Aubrey Sayers, explains “Markets such as India and China offer a lower manufacturing cost base for western pharma companies, but when it comes to pharmaceuticals, the emphasis must still be on production quality. Sepha’s machines offer an automated way of checking the quality of drug packaging which further saves on production costs.”

Within western economies Sepha has also been able to take advantage of the drive by its customers to reduce waste and disposal costs. Sepha’s innovative machines safely remove valuable product from defective packs, allowing them to be repackaged and sold on to the customer. In addition its range of leak testing machines, which are used to detect holes in pharmaceutical blister packs, sachets and pouches, offer a clean, non-destructive alternative to the widely used and messy methylene blue dye leak test which results in unnecessary waste of valuable product, whether the packaging is defective or not.

Sepha is already doing business with many of the world’s top pharmaceutical manufacturers including Boots, Bayer and Wyeth. It has been designing and building machines in Northern Ireland since 1980. A number of internal factors including a focused investment in international sales and marketing and an increase in production capacity combined with the cost saving nature of its machines have allowed Sepha to achieve this growth in adverse market conditions.

###

Read the full story at http://www.prweb.com/releases/Sepha/leaktest/prweb3484744.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Pressure BioSciences, Inc. Announces CE Mark Approval and Compliance with the IEC 61010-1 Standard for a Second PCT-based Instrument, the Barocycler NEP2320
2. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
3. New DNA-based technique for assembly of nano- and micro-sized particles
4. Sigma-Aldrich and Ingenuity Systems Announce Partnership to Create E-Commerce Search Solution Based on Biological Knowledge
5. Biodel to Amend June 30, 2007 10-Q to Correct Non-Cash Share-Based Compensation Expense
6. BioNanomatrix Receives New NCI Grant to Support Development of Chip-Based Nanofluidics Systems for Cell Fractionation
7. DuPont and Plantic Technologies Announce Starch-Based Bio Materials Collaboration
8. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
9. Coherent Announces Restatement Related to Stock-Based Compensation
10. Respironics Acquires Apollo Light Systems, Inc., Expands into Circadian Rhythm Device-Based Therapy Market
11. Stem Cell Science Holds Opportunities as Important Tool for Diabetes Research Beyond Cell-Based Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UK Based Machinery Manufacturer, SEPHA, Thrives Despite Downturn
(Date:6/27/2016)... , ... June 27, 2016 , ... Parallel 6 ... trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which ... with the physician and clinical trial team. , Using the CONSULT module, patients and ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in ... Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio ... practical tips, tools, and strategies for clinical researchers. , “The landscape of how ...
Breaking Biology Technology:
(Date:5/3/2016)... Lithuania , May 3, 2016  Neurotechnology, ... released the MegaMatcher Automated Biometric Identification System ... of large-scale multi-biometric projects. MegaMatcher ABIS can process ... accuracy using any combination of fingerprint, face or ... MegaMatcher SDK and MegaMatcher Accelerator ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
Breaking Biology News(10 mins):